EHA2021 CML Education Session

 

CML Education Session and others

eha logo3

 

- CML Education Session -

Stem cells targeting in CML. On demand from 11 June 2021 09:00 AM CET.

Chair: O Hantschel (Germany)

  • CML Biology. M Deininger (United States)
  • Immune cell contexture and response. S Mustjoki (Finland)
  • Treatment-free remission in CML. FX Mahon (France)

Live Q&A Panel Discussion. 16 June 2021 4:00 PM - 4:45 PM CET, Virtual room 1.

 

- EHA2021 Satellite Simposia -

 

Unmet needs in the later line treatment of CML: understanding patient and physician perspectives. Novartis sponsored. 10 June 2021 1:30 PM - 3:00 PM CET. Virtual room 1.

 Chair: F. Lang (Germany)

  • Welcome and Introduction Segment 
  • Patient and physician perspectives: Are we meeting the goals of treatment in later lines of therapy for CML? L. Machado (Canada) Co-Speaker: F. Lang                  
  • Prioritizing the unmet needs: where do we go from here? F. Lang (Germany)              
  • Exploring novel agents in later line CML. J-V Garcia-Gutierrez (Spain)
  • Live Q&A. F. Lang (Germany). Co-Speaker: L. Machado, J-V Garcia-Gutierrez.

 

- Plenary Sessions -

Plenary Session II: 12 June 2021 3:15 PM - 3:45 PM CET

p202-3 Physiopathology of coagulopathy in hematological malignancies and in COVID-19. Dr. Marcel Levi, The Netherlands.

 

- Joint Symposia -

EHA-CSH Joint Symposium: COVID-19 in hematology 12 June 2021 10:00 AM - 11:00 AM CET. Virtual room 1.

Chairs: J Gribben (United Kingdom) & D Wu (China)

Abnormalities in thrombosis and hemostasis in patients with COVID-19. H Yu (China)